Brief: Ambalal Sarabhai Changes Consideration, Completion Date For Synbiotics Sale
05/03/2021 06:45
March 5 (Reuters) - Ambalal Sarabhai Enterprises Ltd
AMBL.BO :
* APPROVED CHANGE IN CONSIDERATION, COMPLETION DATE FOR
SYNBIOTICS
SALE
Source text for Eikon: ID:nBSE1ZLdld
Further company coverage: AMBL.BO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Ambalal Sarabhai Enterprises
See all newsBrief: Ambalal Sarabhai Enterprises Says Telerad Division Of Unit Signs Agreement With Bolin Technology
Brief: Ambalal Sarabhai Enterprises Says CFO Navinchandra Patel Resigns
Brief: Ambalal Sarabhai Enterprises Names Mohal K. Sarabhai As MD
Brief: Ambalal Sarabhai Enterprises Says Unit Asence Pharma Commences New Oncology And Synthetic API Plant At Ranoli, Vadodara
Brief: India's Ambalal Sarabhai Enterprises Dec-Qtr Consol Net Profit Falls